About Incyte Italia

Incyte is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative therapeutics. R&D and scientific excellence drive Incyte's work and commitment to making a difference in patients' lives.

Our teams have a long experience and success stories behind them. Our goal is to develop the best innovative therapies that can address serious unmet medical needs. We have a growing and constantly developing portfolio of oncology and autoimmune/inflammatory disease medicines.

Incyte is headquartered in Wilmington, Delaware (USA), with operations in North America, Europe and Asia. The Italian office is in Milan, opposite the Lombardy Region building, to demonstrate the desire to become a privileged and credible interlocutor with the institutions, capable of generating significant value in the Italian fabric. Our headquarters are designed and built in a "green" perspective where only energy from renewable sources, low-consumption technologies and eco-sustainable materials are used.